Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Devimistat with HCQ and Chemotherapy in Advanced Solid Tumors
NCT05733000Phase 2Recruiting
- Sponsor
- Northwestern University
- Start
- Mar 2023
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of devimistat in colorectal cancer (CRC), pancreatic cancer (PC), biliary tract carcinoma (BTC), gastroesophageal junction adenocarcinoma, urothelial carcinoma (UC), sponsored by Northwestern University. Started Mar 2023; status: recruiting.
02
Drugs
devimistat
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)biliary tract carcinoma (BTC)gastroesophageal junction adenocarcinomaurothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT05733000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05733000.